A new research perspective was published in Oncotarget's Volume 15 on January 16, 2024, entitled, “Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma.” Multiple ...

GLP-1RA use was associate with lower risks for cardiovascular events among patients with monoclonal gammopathy of undetermined significance and type 2 diabetes. Use of glucagon-like peptide-1 receptor ...

Please provide your email address to receive an email when new articles are posted on . Individuals with obesity and heavy smokers had higher rates of MGUS, a precursor to multiple myeloma. Highly ...

Gene-expression-profiling plus integrated multidisciplinary approach to detect new-generation risk-adapted prognostic index in smoldering myeloma and multiple myeloma (GIMPI). This is an ASCO Meeting ...

Individuals with obesity are more likely to have monoclonal gammopathy of undetermined significance (MGUS), a benign blood condition that often precedes multiple myeloma, according to new research.

Hematologic precursor conditions include monoclonal gammopathy of undetermined significance (MGUS), monoclonal B-cell lymphocytosis (MBL), and clonal hematopoiesis (CH). These conditions are ...

Immunoglobulin M monoclonal gammopathy of undetermined significance (IgM-MUS) was diagnosed in 213 Mayo Clinic patients who were residents of 11 counties in southeastern Minnesota from 1960 to 1994.